Calcium Channel Blockers and POAG Risk

• July 1, 2026

Prospective randomised controlled trial to compare tissue reactions and scarring with polypropylene versus polyglactin 910 sutures in periocular skin

• by Tessa Fayers, John S Vekinis, Laura Ah-Kye, David Parham, Priscilla Anketell, Justin Weir, Roger A’Hern, Ben Parkin

• July 1, 2026

Assessing retina-specific ophthalmic counseling generated by an early public large language model across different levels of clinical urgency

• by Dominic M. Choo, Tyler A. Durham, Kishan G. Patel

• July 1, 2026

FDA Approves New Treatment for Thyroid Eye Disease

Phase 3 THRIVE and THRIVE-2 trials supported approval following improvements in proptosis and diplopia in active and chronic disease.

• by Kathryn Wighton

• June 29, 2026

• 3 min